AstraZeneca PLC
NASDAQ:AZN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
61.03
87.62
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
AstraZeneca PLC
AstraZeneca PLC
Other Current Liabilities
AstraZeneca PLC
Other Current Liabilities Peer Comparison
GSK
INDV
HIK
DPH
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AstraZeneca PLC
LSE:AZN
|
Other Current Liabilities
$2.7B
|
CAGR 3-Years
20%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-2%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Other Current Liabilities
£2.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
|
Indivior PLC
LSE:INDV
|
Other Current Liabilities
$192m
|
CAGR 3-Years
26%
|
CAGR 5-Years
19%
|
CAGR 10-Years
-6%
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Other Current Liabilities
$624m
|
CAGR 3-Years
15%
|
CAGR 5-Years
13%
|
CAGR 10-Years
12%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Other Current Liabilities
£15.6m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-13%
|
|
A
|
Alliance Pharma PLC
LSE:APH
|
Other Current Liabilities
£2.8m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
0%
|
See Also
What is AstraZeneca PLC's Other Current Liabilities?
Other Current Liabilities
2.7B
USD
Based on the financial report for Jun 30, 2024, AstraZeneca PLC's Other Current Liabilities amounts to 2.7B USD.
What is AstraZeneca PLC's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
-2%
Over the last year, the Other Current Liabilities growth was 48%. The average annual Other Current Liabilities growth rates for AstraZeneca PLC have been 20% over the past three years , 12% over the past five years , and -2% over the past ten years .
You don't have any saved screeners yet
